Earnings History Data for Fresh Tracks Therapeutics, Inc. (FRTX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Fresh Tracks Therapeutics, Inc.

Fresh Tracks Therapeutics Inc. is a clinical-stage pharmaceutical company. Its product pipeline includes Cialis(R), Taltz(R), Gemzar(R), Prozac(R), Cymbalta(R), Juvederm(R), Pluvicto(R) and Sofpironium Bromide. Fresh Tracks Therapeutics Inc., formerly known as Brickell Biotech Inc., is based in BOULDER, Colo.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
10-05-2023 AH FRTX Fresh Tracks Therapeutics, Inc. 2.91 -1.14 0.00 -3.60 Fresh Tracks Therapeutics GAAP EPS of -$1.14
[5/10/2023 5:13 PM]
0.5336 0.02 
0.0 0.0 
0.45 - 12.60 75,426 80,000 0
10-11-2022 AH After the close
(Nov 10)
FRTX Fresh Track Therapeutics, Inc. 4.97 -2.07 -1.89 -7.21 Fresh Tracks Therapeutics reports GAAP EPS of -$2.07, revenue of $0.49M
[11/10/2022 4:23 PM]
1.88 0.11 
1.74 -0.03 
1.67 - 18.94 40,904 30,000 177